Correction to “Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9”

Ähnliche Einträge

• Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
  von: Debebe, Zufan, et al.
  Veröffentlicht: (2011)
• The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms
  von: Guo, Zhu-Ling, et al.
  Veröffentlicht: (2016)
• Iron depletion by iron chelators or ferroportin inhibits HIV-1 through the induction of HIF1α, p21 and IKBα and the inhibition of CDK9 and CDK2
  von: Kumari, Namita, et al.
  Veröffentlicht: (2013)
• Intracellular reduction/activation of a disulfide switch in thiosemicarbazone iron chelators
  von: Akam, Eman A., et al.
  Veröffentlicht: (2014)
• Iron Chelators in Photodynamic Therapy Revisited: Synergistic Effect by Novel Highly Active Thiosemicarbazones
  von: Mrozek-Wilczkiewicz, Anna, et al.
  Veröffentlicht: (2014)